VB-111: Updated Phase II data

Updated data from 46 patients with recurrent GBM in the Phase II portion of a 2-stage, dose-escalation, open-label, U.S. and Israeli Phase I/II trial showed that IV VB-111 plus Avastin bevacizumab si...